Literature DB >> 9748257

Identification of a Gialpha binding site on type V adenylyl cyclase.

C W Dessauer1, J J Tesmer, S R Sprang, A G Gilman.   

Abstract

The stimulatory G protein alpha subunit Gsalpha binds within a cleft in adenylyl cyclase formed by the alpha1-alpha2 and alpha3-beta4 loops of the C2 domain. The pseudosymmetry of the C1 and C2 domains of adenylyl cyclase suggests that the homologous inhibitory alpha subunit Gialpha could bind to the analogous cleft within C1. We demonstrate that myristoylated guanosine 5'-3-O-(thio)triphosphate-Gialpha1 forms a stable complex with the C1 (but not the C2) domain of type V adenylyl cyclase. Mutagenesis of the membrane-bound enzyme identified residues whose alteration either increased or substantially decreased the IC50 for inhibition by Gialpha1. These mutations suggest binding of Gialpha within the cleft formed by the alpha2 and alpha3 helices of C1, analogous to the Gsalpha binding site in C2. Adenylyl cyclase activity reconstituted by mixture of the C1 and C2 domains of type V adenylyl cyclase was also inhibited by Gialpha. The C1b domain of the type V enzyme contributed to affinity for Gialpha, but the source of C2 had little effect. Mutations in this soluble system faithfully reflected the phenotypes observed with the membrane-bound enzyme. The pseudosymmetrical structure of adenylyl cyclase permits bidirectional regulation of activity by homologous G protein alpha subunits.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9748257     DOI: 10.1074/jbc.273.40.25831

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Regions on adenylyl cyclase that are necessary for inhibition of activity by beta gamma and G(ialpha) subunits of heterotrimeric G proteins.

Authors:  C Wittpoth; K Scholich; Y Yigzaw; T M Stringfield; T B Patel
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

2.  The A-kinase anchoring protein Yotiao facilitates complex formation between adenylyl cyclase type 9 and the IKs potassium channel in heart.

Authors:  Yong Li; Lei Chen; Robert S Kass; Carmen W Dessauer
Journal:  J Biol Chem       Date:  2012-07-09       Impact factor: 5.157

Review 3.  Nanometric targeting of type 9 adenylyl cyclase in heart.

Authors:  Autumn N Marsden; Carmen W Dessauer
Journal:  Biochem Soc Trans       Date:  2019-12-20       Impact factor: 5.407

4.  Regulation of adenylate cyclase type VIII splice variants by acute and chronic Gi/o-coupled receptor activation.

Authors:  Debora Steiner; Tomer Avidor-Reiss; Ester Schallmach; Elena Butovsky; Nirit Lev; Zvi Vogel
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

Review 5.  Molecular details of cAMP generation in mammalian cells: a tale of two systems.

Authors:  Margarita Kamenetsky; Sabine Middelhaufe; Erin M Bank; Lonny R Levin; Jochen Buck; Clemens Steegborn
Journal:  J Mol Biol       Date:  2006-07-28       Impact factor: 5.469

6.  Minimal determinants for binding activated G alpha from the structure of a G alpha(i1)-peptide dimer.

Authors:  Christopher A Johnston; Ekaterina S Lobanova; Alexander S Shavkunov; Justin Low; J Kevin Ramer; Rainer Blaesius; Zoey Fredericks; Francis S Willard; Brian Kuhlman; Vadim Y Arshavsky; David P Siderovski
Journal:  Biochemistry       Date:  2006-09-26       Impact factor: 3.162

7.  Expansion of signal transduction by G proteins. The second 15 years or so: from 3 to 16 alpha subunits plus betagamma dimers.

Authors:  Lutz Birnbaumer
Journal:  Biochim Biophys Acta       Date:  2006-12-15

8.  Regulation of type V adenylate cyclase by Ric8a, a guanine nucleotide exchange factor.

Authors:  Shyi-Chyi Wang; Hsing-Lin Lai; Yi-Ting Chiu; Ren Ou; Chuen-Lin Huang; Yijuang Chern
Journal:  Biochem J       Date:  2007-09-15       Impact factor: 3.857

9.  N terminus of type 5 adenylyl cyclase scaffolds Gs heterotrimer.

Authors:  Rachna Sadana; Nathan Dascal; Carmen W Dessauer
Journal:  Mol Pharmacol       Date:  2009-09-25       Impact factor: 4.436

10.  Functional characterization of AC5 gain-of-function variants: Impact on the molecular basis of ADCY5-related dyskinesia.

Authors:  T B Doyle; M P Hayes; D H Chen; W H Raskind; V J Watts
Journal:  Biochem Pharmacol       Date:  2019-02-14       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.